4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-15-000065
$BHCCIK 0000885590operating
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:54 PM ET
Size
6.4 KB
Accession
0000885590-15-000065
Insider Transaction Report
Form 4
Rosiello Robert L.
EVP, Chief Financial Officer
Transactions
- Purchase
Common Stock, no par value
2015-07-31$257.25/sh+704$181,104→ 441,675 total - Purchase
Common Stock, no par value
2015-07-30$253.99/sh+7,171$1,821,362→ 440,971 total
Footnotes (1)
- [F1]This number represents the weighted average purchase price for all sales of common stock purchased by the reporting officer.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:54 PM ET
- Size
- 6.4 KB